RHUMBLINE ADVISERS - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$3,546,979
+83.7%
150,169
+16.0%
0.00%
+100.0%
Q3 2023$1,930,894
+39.9%
129,504
+2.8%
0.00%0.0%
Q2 2023$1,379,984
+336.7%
126,026
+24.0%
0.00%
Q1 2022$316,000
-11.5%
101,595
-3.9%
0.00%
Q4 2021$357,000
-8.0%
105,702
-0.5%
0.00%
-100.0%
Q3 2021$388,000
-14.5%
106,187
+2.0%
0.00%0.0%
Q2 2021$454,000
-14.2%
104,101
-10.6%
0.00%0.0%
Q1 2021$529,000
-24.4%
116,461
-4.5%
0.00%0.0%
Q4 2020$700,000
-9.9%
121,941
+13.6%
0.00%0.0%
Q3 2020$777,000
+83.3%
107,360
-11.7%
0.00%0.0%
Q2 2020$424,000
+236.5%
121,525
+43.2%
0.00%
Q1 2020$126,000
-24.1%
84,8870.0%0.00%
Q4 2019$166,000
-61.8%
84,887
-0.1%
0.00%
-100.0%
Q3 2019$435,000
-29.0%
85,005
-0.7%
0.00%0.0%
Q2 2019$613,000
-40.7%
85,580
+9.9%
0.00%
-50.0%
Q1 2019$1,034,000
+68.7%
77,843
-0.1%
0.00%
+100.0%
Q4 2018$613,000
+4.6%
77,946
+47.4%
0.00%0.0%
Q3 2018$586,000
-21.0%
52,889
-4.3%
0.00%0.0%
Q2 2018$742,00055,2610.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$11,887,0008.85%
Foresite Capital Management IV, LLC 1,787,094$12,939,0002.92%
Copernicus Capital Management, LLC 278,416$2,016,0001.92%
Sio Capital Management, LLC 1,159,236$8,393,0001.66%
ACUTA CAPITAL PARTNERS, LLC 765,000$5,539,0001.50%
Avoro Capital Advisors LLC 10,300,000$74,572,0001.06%
Boxer Capital, LLC 4,000,000$28,960,0001.00%
Vivo Capital, LLC 2,089,356$15,127,0000.87%
EAM Global Investors LLC 284,534$2,060,0000.76%
Versant Venture Management, LLC 543,753$3,937,0000.72%
View complete list of CYMABAY THERAPEUTICS INC shareholders